Drug Shortage Report for REPAGLINIDE

Last updated on 2019-01-12 History
Report ID 35070
Drug Identification Number 02415968
Brand name REPAGLINIDE
Common or Proper name REPAGLINIDE
Company Name PRO DOC LIMITEE
Active Ingredient(s) REPAGLINIDE
Strength(s) 0.5MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code A10BX
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2018-11-15
Estimated end date
Actual end date 2019-01-11
Shortage status Resolved
Updated date 2019-01-12
Company comments
Health Canada comments
Contact Address 2925 BOULEVARD INDUSTRIEL
LAVAL, QUEBEC
CANADA H7L 3W9
Company contact information 2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v18 2019-01-12 English Compare
v17 2019-01-11 French Compare
v16 2019-01-11 English Compare
v15 2019-01-08 French Compare
v14 2019-01-08 English Compare
v13 2018-11-16 English Compare
v12 2018-11-15 French Compare
v11 2018-11-15 English Compare
v10 2018-04-03 French Compare
v9 2018-04-03 English Compare
v8 2018-03-26 French Compare
v7 2018-03-26 English Compare
v6 2018-03-20 French Compare
v5 2018-03-20 English Compare
v4 2018-02-13 French Compare
v3 2018-02-13 English Compare
v2 2018-01-05 French Compare
v1 2018-01-05 English Compare